Literature DB >> 7189791

Chemotherapy of hormone-resistant stage D prostatic cancer.

J D Schmidt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189791     DOI: 10.1016/s0022-5347(17)56140-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

Review 1.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 3: Cancer of the prostate.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-03       Impact factor: 1.798

3.  The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.

Authors:  Guru Sonpavde; Gregory R Pond; William R Berry; Ronald de Wit; Mario A Eisenberger; Ian F Tannock; Andrew J Armstrong
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

Review 4.  Chemotherapy for advanced prostate cancer: results of new clinical trials and future studies.

Authors:  Andrew J Armstrong; Michael A Carducci
Journal:  Curr Oncol Rep       Date:  2005-05       Impact factor: 5.075

5.  Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors:  B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.